Introduction
The development of nucleotide sequencing techniques has been contributing greatly, in combination with the use of monoclonal antibodies, to rapid progress in the study of rabies, particularly with regard to the antigenic structures of the viral surface glycoprotein (G) and the mechanisms of neurovirulence of the virus (Dietzschold et al., 1983 ; Prehaud et al., 1988; Seif et al., 1985) . Many kinds of gene expression systems, including recombinants of vaccinia virus (Kieny et al., 1984; Rupprecht et al., 1986) , adenovirus (Prevec et al., 1990 ) and baculovirus (Prehaud et al., 1989) , have also been used for studies on the rabies virus G protein, particularly for developing rabies virus subunit vaccines. Recent progress in the study of post-translational processing and intracellular transport of glycoproteins of many enveloped viruses has been accelerated greatly by the successful application of eukaryotic expression vector systems and other cDNA-manipulating techniques, for example the production of mutants or hybrid genes (Machamer & Rose, 1988a, b; Puddington et al., 1987) . These cDNA manipulation techniques could also provide useful tools for further studies on the rabies virus G protein, particularly for more detailed studies of the molecular and antigenic structures of the protein and of the interactions between the G protein and other viral or cellular constituents in the cell.
The G protein of the rabies virus is thought to be one of the important antigens that are required for and involved in induction of anti-rabies virus antibodies and cellular immunity (Wiktor et al., 1973; Cox et al., 1977; Kawano et al., 1990; Cells et al., 1990) . Accordingly, cDNA of the rabies virus G protein gene has been used for the development of new rabies vaccines. Furthermore, the antigenic structures recognized by the specific cytotoxic T lymphocytes (CTLs) have also been studied, but still remain to be investigated more precisely (MacFarlan et al., 1984) . Since we have isolated rabies virus-specific murine CTL clones from mice which had been immunized with virions of the HEP-Flury strain (Cho et al., 1987) , and have also cloned and sequenced a full-length cDNA of the G gene of the same strain (Morimoto et al., 1989) , we planned to use these CTL clones and G cDNA with suitable eukaryotic expression vectors to investigate the antigenic structures of the G protein that are 0001-0280 © 1992 SGM recognized by these CTL clones. In this report, we describe the establishment and characterization of G cDNA-transfected animal cells [BHK-21 and mouse neuroblastoma C 1300 (clone NA) cells], which displayed constitutive and inducible expression of rabies virus G protein, respectively. They served as useful targets for the rabies virus-specific CTL clones. We also describe differences in the structure of the carbohydrate sidechains of G proteins that were produced by these transformants.
Methods
Virus and cell cultures. We used the HEP strain of rabies virus, clone 2150-14 (Kawai et al., 1975) , which was the same clone as that used for the eDNA cloning (Morimoto et al., 1989) . Defective interfering particle-free stocks of the virus were prepared and titrated as described by Kawai & Matsumoto (1982) . BHK-21 cells were usually propagated at 36 °C in Eagle's MEM which was supplemented with 10% tryptose phosphate broth (Difco) and 5% bovine serum. The murine neuroblastoma cell line C1300, clone NA, was grown at 36 °C in Eagle's MEM supplemented with 10% foetal calf serum.
Construction of an expression vector (pSVX-G) for production of the rabies G protein in animal cells.
A murine retroviral vector, pZIPNeoSV(X)I (Cepko et al., 1984) , was used for producing the rabies virus G protein in mammalian cells. The vector allows dual gene expression by producing unspliced and spliced transcripts, which are translated into polypeptides encoded by a foreign gene and the intrinsic neomycin resistance (Neo R) gene, respectively, cDNA of the rabies virus G gene (HEP strain), cloned into pBR322 and designated pHP452 (Morimoto et al., 1989) , was inserted into the BamHI site of the expression vector as follows (Fig. 1) . Plasmid pHP452 was first digested with AfllI (a single AfllI site existed eight bases upstream from the translational start codon), and a BamHI linker was attached to the end of the AflII cut which had been made blunt in advance by the Klenow enzyme. Then a DNA fragment of 1-65 kb containing the entire coding region of the gene was cut out with BamHI (a BamHI site existed 71 bases downstream from the stop codon), inserted into the BamHI site of pZIP-NeoSV(X)I and ligated by T4 DNA ligase. The reconstructed expression vector obtained is referred to as pSVX-G in this study. Manipulations of DNA were performed as described by Maniatis et al. (1982) . The BamHI linker, restriction enzymes and other DNA-modifying enzymes were purchased from Takara Shuzo and Toyobo.
Isolation of the G418-resistant transformants containing the transfected G gene. Transfections of pSVX-G DNA into BHK-21 and NA cells were performed by the DEAE-dextran and calcium phosphate methods, respectively (Lopata et al., 1984; Davis et al., 1986) . The transfected cells were cultivated (usually for 2 to 3 weeks) in the presence of 400 lag/ml G418 from 48 h after the glycerol shock, and culture medium containing 400 p.g/ml G418 was changed at 3 day intervals until the isolation of the G418-resistant clones. Isolated G418-resistant clones (referred to as G-BHK and G-NA cells in this paper) were propagated in the presence of 400 p_g/ml G418.
Fluorescent antibody (FA) staining.
To examine the production of the G protein, transformants sown on coverslips were fixed with acetone for 5 rain at room temperature and subjected to indirect FA staining, for which a rabbit antiserum produced against the G protein (Naito & Matsumoto, 1978) Fig. 1 . Construction of plasmid vector pSVX-G. The AfllI-BamHI fragment (1-65 kb) was cut out from a G cDNA clone (ptfP452) of the rabies virus HEP strain and was inserted into the BamHI site of the retroviral expression vector pZIP-NeoSV(X)I (Cepko et al., 1984) as noted in Methods. Symbols: G, cDNA of the G protein; A, 3' splicing site; Neo, neomycin resistance (Neo R) gene derived from transposon Tn5; B and C, simian virus 40 and pBR322 origins of replication. The LTR originated from the Moloney murine leukaemia virus. The arrow below the G cDNA insert in pHP452 indicates the 5' to 3' direction of the plus-strand of the cDNA. Long straight arrows depicted below the genes in the retroviral vector indicate production of unspliced mRNA for expression of the insert at the BamHI site, and bent ones indicate production of spliced mRNA for expression of the Neo R gene.
the second antibody. For testing the presence of the G antigen on the cell surface by FA staining, the cells were fixed with 3% paraformaldehyde.
SDS-PAGE.
This was performed by using 10% polyacrylamide gel and Laemmli's discontinuous buffer system (Laemmli, 1970) . lmmunoblot analysis. Cells were lysed with IP buffer which was composed of 1% Triton X-100, 1% deoxycholate, 10 mM-Tris-HCl pH 7.4, 150 mM-NaCI, 1 mM-PMSF and 1 I~g/ml antipain. After nuclei had been removed by low speed centrifugation, the lysate was mixed with the same volume of double-concentration SDS PAGE lysis buffer, and then subjected to 10% SDS-PAGE. The proteins separated in the gel were blotted onto nitrocellulose membrane filters (BA85, Schleicher & Schfill) by the semi-dry method described by Kyhse-Andersen (1984) . The filter was then incubated with the rabbit anti-G serum as the first antibody and peroxidase-conjugated anti-rabbit serum as the second antibody. The colour reaction was performed by using 4-chloro-1-naphthol (Towbin et al., 1979; Hawkes et al., 1982) .
Radiolabelling of cells with [3 H]leucine.
[3H]Leucine-labelling of G-BHK (clone 6) cells was performed as follows. Cells (106 on a 35 mm dish) were first incubated in leucine-free Eagle's MEM for 90 to 120 min, and then 100 p.Ci/ml L-[4,5-3H]leucine (Amersham; specific activity 139 Ci/mmol) was added to the cultures, which were then incubated for 6 to 7 h. The labelled cells were washed several times with PBS and then lysed with IP buffer and, after removal of the nuclei by low speed centrifugation, they were immunoprecipitated, and subjected to SDS-PAGE and fluorography.
Radiolabelled lysates of virus-infected BHK-21 cells were also prepared, as described elsewhere (Kawai & Matsumoto, 1981) . In brief, monolayers of BHK-21 cells were infected with rabies virus at a multiplicity of 5 p.f.u./cell. After an initial incubation for 35 h at 36 °C, they were preincubated for 1 h in leucine-free MEM, and then 50 ~tCi/ml [3H]leucine was added to the cultures. After further incubation for 8 h, they were washed several times with PBS and lysed with IP buffer.
For labelling the unglycosylated form of the G protein, both G418-resistant transformants and virus-infected cells were treated with 0.5 ~tg/ml tunicamycin (Sigma) during the radioisotope-free preincubation and radiolabelling periods. Lysates of 35S-labelled virus-infected cells were prepared in the same way in the presence or absence of tunicamycin as described above, except [35S]methionine was used instead of [3H]leucine.
Fluorography. Radiolabelled proteins separated in 10 % SDS-PAGE gels were subjected to the fiuorographic procedures described by Chamberlain (1979) . The salicylate-impregnated dried gel was put in contact with X-ray film (Kodak X-OMat AR) for an appropriate number of days at -70 °C.
Immunoprecipitation of the G protein.
The lysates of the radiolabelled cells prepared as described above were mixed with 5 % SDS solution to achieve a final SDS concentration of 0-45%, and then processed for immunoprecipitation as follows. Each lysate (corresponding to 5 x 105 cells) was treated overnight at 4 °C with 4 txl of the rabbit anti-G serum and, after being mixed with an appropriate amount of Pansorbin (Calbiochem), the sample was incubated for 2 h at 4 °C. Precipitates were obtained by centrifugation for 1 min in a Microfuge (model B, Beckman) and washed five times with IP buffer containing 0-45 % SDS, and then subjected to 10% SDS-PAGE and fluorography.
Neuraminidase treatment. Radiolabelled immunoprecipitates of the G protein obtained as described above were washed twice with a 100 mM-sodium acetate buffer (pH 5.6) containing 1 mM-CaCIz, 2 mM-PMSF and 1 ~tg/ml antipain. They were finally suspended in 200 ~tl of sodium acetate buffer, to which 60 milliunits (mU) of neuraminidase type V (Sigma) was added. Reaction mixtures were incubated for 16 h at 37 °C, and then centrifuged in a Microfuge, suspended in 80 p.l of SDS-PAGE lysis buffer and subjected to SDS-PAGE and fluorography.
Estimation of the number of otigosaccharide side-chains on the G protein molecule.
One-million cells in a 35 mm dish were labelled in advance with 100 ktCi/ml [3sS]methionine (Amersham; specific activity 1175 Ci/mmol) for 1 h in the presence of 2 mM-N-methyl-l-deoxynojirimycin (Genzyme) (Romero et al., 1983) , and then lysed with 200 ~tl of IP buffer and processed for immunoprecipitation as described above. The immunoprecipitates obtained (which corresponded to 2 x 106 cells) were dissolved again with 200 )11 of 0.15 M-citrate-phosphate buffer pH 5-0 containing 1 mM-PMSF and subjected to limited digestion with glycosidase as follows. The sample was divided into four equal parts, each of which was treated with 1 mU of endoglycosidase H (endo H) (Seikagaku-Kogyou) for various periods at 37°C, so that the oligosaccharide chains were removed partially or completely from each glycoprotein molecule, depending on the duration of digestion (Rottet al., 1984) . Each digest was then analysed by 10% SDS-PAGE and fluorography.
Cytotoxicity test with the CTL clones. We used rabies virus-specific CTL clones established previously from A/J mice, and the cytotoxicity assays were performed as described before (Cho et al., 1987; Kawano et al., 1990) . Target cells, which had been labelled with 20 gCi/ml 51CrNa204 for 8 h, were placed into fiat-bottomed 96-well plates, and mixed with serial dilutions of a suspension of the CTL clone. The reaction was terminated after incubation for 8 h at 37 °C. The percentage specific lysis was obtained by calculating: 100 x (~lCr released with effector cells -sl Cr released without effector cells)/( s x Cr released with 1% Triton X-100 -51Cr released without effector cells).
Results

Establishment of G418-resistant BHK-21 (G-BHK) cells
We planned to establish cell lines which constitutively produce the rabies virus G protein by transfecting a cloned G-cDNA into animal cells, such as BHK-21 and mouse neuroblastoma C1300 (clone NA) cells, which have long been used as highly permissive host cells for rabies virus replication in culture. Owing to its efficient promoter activity in a broad range of mammalian cells, we chose the murine retroviral vector pZIP-NeoSV(X)1 (Cepko et al., 1984) . This vector has a neomycin resistance gene that would allow selection of recipient cells with the ability to grow in the presence of an antibiotic, G418, and thereby G418-resistant transformants could be isolated. As shown in Fig. 1 , we reconstructed a recombinant plasmid, pSVX-G, for expressing the G cDNA (see also Methods).
We isolated several G418-resistant clones from BHK-21 cell cultures which had been transfected with pSVX-G. The ability of these clones (referred to as G-BHK in this study) to produce the G antigen was examined by FA staining. Fig. 2 shows one (clone 6) of the fluorescencepositive G-BHK clones. Bright fluorescence due to the G antigen was present in the cytoplasm of acetone-fixed G-BHK cells, particularly in a central region near the nucleus, which seemed to correspond to the Golgi area (Fig. 2a) . The antigen was also detected on the surface of cells which had been fixed with 3 % paraformaldehyde (Fig. 2b) , suggesting that G protein molecules were transported to the surface of G-BHK cells in the normal way. Although almost all of the cells produced the G antigen, the strength of the fluorescence varied greatly from cell to cell (Fig. 2e) . Similar observations were also made for the other G-BHK clones we isolated. Continuous production of the antigen was observed in all G-BHK cell cultures during subsequent cell passages.
Establishment of G418-resistant murine neuroblastoma NA (G-NA) cells
Next, we tried to isolate NA cells that would constitutively produce the G protein; we selected more than 20 G418-resistant clones (referred to as G-NA ceils) from G-cDNA-transfected NA cell cultures, all of which, however, were shown to be FA-negative, unlike the G-BHK cell clones. G-NA cells displayed a weak fluores- cence, which was almost indistinguishable from that of untreated parental NA cells (Fig. 3 a and c) . Accordingly, no G antigen was detected by the immunoblot method in G-NA cells (see below). Furthermore we could not find any FA-positive (G protein-producing) cells in uncloned mixed cultures composed of more than 100 G-NA clones.
We examined whether the G-NA cells could be induced to produce the G protein by treating them with differentiation-inducing agents. Although 5-bromodeoxyuridine and dibutyryl cyclic AMP induced morphological changes of the NA cells, neither induced G protein synthesis (data not shown). However the G protein was synthesized after treatment with sodium butyrate (Fig. 3b) which is known to stimulate the promoter activity of the long terminal repeat (LTR) (Gorman & Howard, 1983; Bohan et al., 1987) . Immunoblot analysis revealed that the maximum level of G protein synthesis was induced in G-NA cells by 5 mMsodium butyrate (Fig. 4a) .
To estimate the relative amount of G proteins produced by G-NA cells, we performed quantitative immunoblot assays by comparing the colour intensity on the immunoblot sheet of the band of G protein in a series of twofold diluted lysates of sodium butyrate-treated G-NA and virus-infected NA cells. The results showed that the amount of G protein in 5 x 104 butyrate-treated G-NA cells was almost equal to that in about 1.5 x 103 virus-infected NA cells. In other words, the estimated amount of G protein accumulated in sodium butyratetreated G-NA cells was at most 3~ of that produced by virus-infected NA cells. The amount of G protein in untreated G-NA cells was also checked similarly, and was shown to be much less than a tenth of those treated with sodium butyrate, being too low to be determined more precisely by the immunoblot assay. On the other hand, G-BHK cells, whether treated with sodium butyrate or not, synthesized an amount of G protein comparable to that in sodium butyrate-treated G-NA cells (Fig. 4b) . Also, they seemed to be stimulated only slightly by the drug to produce the G protein.
Cell division of G-NA and parental NA cells ceased after treatment with sodium butyrate, and they began to change morphology. Fig. 3 (b) shows the immunofluorescence of G-NA cells which were fixed on day 4 after the butyrate treatment. Round-shaped NA ceils became fiat and extended protoplasmic protrusions from the cell body, whose fluorescence coincidently became brighter. When the sodium butyrate was removed from the culture, the morphology of the cell body reverted to the original round shape and G protein synthesis stopped.
We next investigated the time course of G protein synthesis by G-NA cells and the morphological alterations after the addition of sodium butyrate. At daily intervals after sodium butyrate treatment, G protein production was monitored by the immunoblot method and FA staining with anti-G serum. Fig. 5 shows the results of such an experiment performed with one of the G-NA clones. G-NA cells, which were maintained in the presence of G418 during the consecutive cell passages, began to produce G protein whenever sodium butyrate was added to the culture. Immunoblot assays demonstrated that production of the G protein in the G -N A cell culture (clone 1A) reached a plateau on day 4. The cells had begun to cease division on day 2 after treatment, whereas morphological changes of the cell began to appear gradually, but fiat cells with cytoplasmic protrusions were frequently observed on day 4. Similar kinetics of morphological change were also obtained with some other G-NA clones. Parental NA cells displayed a similar morphological change upon treatment with the drug, but the fluorescence was always negative (Fig. 3 d) . FA staining of paraformaldehyde-fixed specimens revealed that G proteins produced by G-NA cells were transported to the surface of the cell in the normal way, as in virus-infected cells (data not shown). 
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Comparisons of G protein molecules produced by G-BHK and G-NA cells
As shown in Fig. 4 (a) , we observed no notable difference in the electrophoretic mobility of the G proteins produced by the G-NA and rabies virus-infected NA cells. But occasionally G proteins from G-NA cells contained two components of different mobilities, one of which migrated at a slower rate (Fig. 7d) . However, the G proteins produced by G-BHK cells always migrated apparently at a slower rate than those produced by virusinfected BHK cells ( Fig. 4b and 6a) . Accordingly, we performed more detailed studies on the structure of G proteins produced by G-BHK and G-NA cells. First, we compared the unglycosylated form (Go) of the protein produced in the presence of tunicamycin, which blocks N-linked glycosylation (Takatsuki et al., 1975) . As shown in Fig. 6(b) , we could not find any difference in the electrophoretic mobility of the unglycosylated Go proteins produced in the presence of tunicamycin by G-BHK and virus-infected BHK cells. There was also no difference in the electrophoretic mobility of Go proteins produced by sodium butyratetreated G-NA and virus-infected NA cells (data not shown). The Mr of the Go protein estimated from the electrophoretic mobility corresponded well with the predicted value (56499), which was calculated from the deduced amino acid sequence (Morimoto et al., 1989) . Although many bands of immunoprecipitants were detected from the samples obtained from tunicamycintreated G-BHK cells (Fig. 6b, lane 4) , these multiple additional bands were not specific precipitatants, because all but one were eliminated by repeating the immunoprecipitation procedures (Fig. 6c, lane 5) . These results suggest that the apparent differences in the electrophoretic mobility of the G protein are due to differences in the carbohydrate moiety of the protein.
It is known that the structures of the carbohydrate moieties of viral glycoproteins are dependent on the host cells in which the viruses replicated, and are fairly heterogeneous (Robertson et al., 1976) ; heterogeneity of the sialic acid content has also been reported for rabies virus G proteins (Dietzschold, 1977) . Consequently, we next examined the effects of neuraminidase treatment on the electrophoretic mobility of the G proteins (Fig. 6c ), but this affected the mobility of G proteins which were produced by rabies virus-infected cells by only a small degree (Fig. 6c, lanes 6 and 7) . In contrast, the mobility of G proteins from G-BHK cells was much accelerated by the treatment (Fig. 6c, lanes 8 and 9) , but was still considerably slower than those from the virus-infected cells (Fig. 6c, lanes 7 and 9) . These observations indicate that the content of sialic acid in the carbohydrate sidechains was much higher in G proteins from G-BHK cells than those from virus-infected BHK-21 cells.
From the differences in the electrophoretic mobility observed even after neuraminidase treatment (indicated by dots and arrows on lanes 5, 7 and 9 in Fig. 6c ), we also assumed that numbers of oligosaccharide side-chains differ between G proteins produced by G-BHK and virus-infected BHK-21 cells. This assumption was confirmed by estimating the number of carbohydrate side-chains on the glycoprotein (Fig. 7) , in which we used endo H and a nojirimycin derivative, a drug that inhibits the trimming process of the outermost glucose residues on the N-linked precursor oligosaccharide side-chains (Rott et al., 1984) . Fig. 7 (a) and (c) show that most G proteins produced by G-BHK cells had two, but occasionally had one or three oligosaccharide chains, whereas those produced in the virus-infected BHK-21 cells had only one chain, and rarely two. As for the G proteins from the virus-infected NA cells, most of them had one oligosaccharide chain (Fig. 7b) . On the other hand, G proteins produced by G-NA cells had mostly one oligosaccharide chain, but some of them had two. In some cases, however, we observed that half or more of the G proteins produced by G-NA cells had two oligosaccharide chains rather than one, but Immunoprecipitants obtained in the same way as described for (a) (without tunicamycin), but were further incubated with 60 mU of neuraminidase (lanes 7 and 9) or without (lanes 6 and 8) for 16 h at 37 °C. Lanes 6 and 7, G proteins from rabies virus-infected BHK-21 cells; lanes 8 and 9, G proteins from G-BHK (clone 6) cells. Lane 5, Go protein, displayed as the reference, which was obtained from the same sample shown in lane 4, but the procedures of immunoprecipitation were repeated twice. Lanes M, whole lysate of the [3H]leucinelabelled rabies virus-infected BHK-21 ceils, used as a marker. Arrows indicate G proteins of different mobilities, including those which were treated with neuraminidase.
never three, as shown in Fig. 7 (d) . It is also notable that the numbers of oligosaccharide chains were different between the G proteins which were produced by G -B H K and G -N A cells ( Fig. 7c and d) , suggesting that glycosylation at the putative glycosylation sites is dependent on the species and/or conditions of the host cells.
Cytotoxicity of rabies-specific C T L clones to G-NA cell
Finally, we examined whether G -N A cells serve as target cells for the specific CTLs of the A/J strain (H-2 a) of mouse, the strain from which the N A cells were derived. From spleen cells of the mice immunized with the H E PFlury strain of rabies virus, we have established C T L clones that recognize the G protein of the virus and display H-2-restricted specific cytotoxicity against virusinfected target cells (Cho et al., 1987 ; K a w a n o et al ., 1990) . Along with these studies, we subjected the G -N A cells to a cytotoxicity test with these G antigen-specific C T L clones. Fig. 8 shows one of the representative results of the cytotoxicity tests on G -N A cells (clone 1A), which demonstrates that G -N A cells were specifically lysed by the rabies-specific C T L clone (DD-12). Untreated G-N A cells were lysed by DD-12, whereas normal N A cells were not at all. On the other hand, the lysis of G -N A cells by DD-12 was much increased by treatment with 5 mMsodium butyrate, but complete lysis was not observed. produced the G protein only when they had been treated with sodium butyrate, whereas all the G-BHK Clones constitutively produced G protein regardless of sodium butyrate treatment. It has been reported that the LTR of Moloney murine leukaemia virus, which was used in the vector and is known to be active in many types of animal cells, does not necessarily function well in undifferentiated cells (Hilberg et al., 1987) . Sodium butyrate is known to increase the promoter activity of the LTR (Gorman & Howard, 1983) . The NA cell line (an HGPRT-negative clone) originated from a mouse neuroblastoma (C1300) which can be induced to develop some differentiated characteristics by treatment with differentiation-inducing agents including sodium butyrate (Schneider, 1976) . At present, we suppose that the different levels of cellular differentiation of BHK-21 and NA cells may account for the different modes of G gene expression in these cells, and sodium butyrate-induced production of G protein in G-N A cells is mediated either by activating the promoter (LTR) of the vector, or indirectly through the induction of differentiation of the cells.
In this study, we could demonstrate that G-NA cells served as a useful target for the rabies virus-specific CTL clones. The sensitivity of G-NA cells to these clones was increased considerably by treatment with sodium butyrate, but the amount of G protein in the sodium butyratetreated cells was at most 3% that of the virus-infected cells, which may be one of the reasons for the incomplete lysis of the G-NA cells. Untreated G-NA cells were also fairly susceptible to cytotoxicity, indicating that a proportion of untreated G-NA cells constitutively produced some G protein, but in amounts too small to be detected by the usual methods of immunofluorescence and immunoblotting. This assumption is not inconsistent with the fact that isolation of G-NA clones depended on the promoter activity of the vector pSVX-G capable of expressing dually the neomycin resistance and rabies virus G genes.
We observed that G proteins produced by G-NA cells were glycosylated less frequently than those produced by G-BHK cells. This observation resembles previous findings that the carbohydrate compositions of the viral glycoprotein were dependent on the host cell species in which the virus replicated (Etchison & Holland, 1974; Hsieh et al., 1983) . Another possibility is that the reduced numbers of carbohydrate side-chains on the G protein produced by the G-NA cells may be related to some malignant nature of NA cells that was retained even after the induction of cellular differentiation with sodium butyrate.
In this study, we also found differences in the content of sialic acid as well as in the numbers of oligosaccharide side-chains between the G proteins produced by G-BHK and virus-infected BHK-21 cells. The decreased sialylation and glycosylation of the G protein might be caused either by a virus-induced inhibitory effect on the sialylating and/or glycosylating apparatus of the cell or by synthesis of G proteins at such a rate that the modification pathways became saturated. But there is another possibility. Table 1 compares the potential glycosylation sites on the G protein molecule which have been predicted for four strains (ERA, CVS, PV and HEP-Flury) of rabies virus (Anilionis et al., 1981 ; Yelverton et al., 1983; Tordo et al., 1986; Morimoto et al., 1989) . Only two sites, Asn 37 and Asn 319, are common to all four strains. For the G protein of the CVS strain, Wunner et al. (1985) reported that the frequency of glycosylation at Asn 204 was variable, probably dependent on the different conformations caused by intramolecular disulphide bridges, whereas Asn 319 was usually glycosylated and Asn 37 was not. They also described a variant of this strain that had an additional glycosylation site at position 158 of the G protein, which was actually glycosylated. From these considerations, we supposed that the G cDNA of the HEP strain we had cloned encoded an additional glycosylation site, which may account for the observed difference in the numbers of carbohydrate side-chains on the G protein produced by G cDNA-carrying and virusinfected cells.
Consequently, we checked the nucleotide sequence and the deduced amino acid sequence of the G protein by sequencing the RNA genome of the virion by using the et al. (1983) * A variant of the CVS strain was reported which had the signal at Asn 158 (Wunner et al., 1985) .
dideoxynucleotide method with reverse transcriptase and synthetic oligonucleotide primers. It was revealed that the genome lacked one (Asn 158) of three putative glycosylation sites predicted from the cloned G cDNA (unpublished observation). For this additional site (Asn 158) on the G cDNA-encoded G protein, we can assume that the site was either generated during the cloning process by a substitution of only one nucleotide at the corresponding site, or that we isolated a clone that encoded a G protein with Asn 158 from the cDNAs of a mutated virus that had been present already in the virus stock. In either case, the additional Asn 158 putative glycosylation site may account partly for the higher numbers of oligosaccharide side-chains on the G proteins produced by G cDNA-carrying cells compared to those produced by virus-infected cells.
